Fundacao Antonio Prudente Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2015
NCT02609828
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Fundacao Antonio Prudente | Fundacao Antonio Prudente - Hospital A.C. Camargo/Hospital do Cancer